FILSPARI
LIVE

Serial Number

90818374

Owner

TRAVERE THERAPEUTICS, INC.

Attorney

Jared M. Barrett

First Use Date

Feb 17, 2023

Filing Date

Jul 8, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FILSPARI Trademark

Serial Number: 90818374 • Registration: 7044077

FILSPARI is a trademark filed by TRAVERE THERAPEUTICS, INC. on July 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

TRAVERE THERAPEUTICS, INC. (67 trademarks)

SUITE 300
SAN DIEGO, CA 92130

Entity Type: 03

Trademark Details

Filing Date

July 8, 2021

Registration Date

May 2, 2023

First Use Anywhere

February 17, 2023

First Use in Commerce

February 17, 2023

Published for Opposition

May 3, 2022

Goods & Services

pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 2, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 2, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 31, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 30, 2023 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Mar 9, 2023 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 9, 2023 AITU
USE AMENDMENT FILED
Feb 22, 2023 IUAF
TEAS STATEMENT OF USE RECEIVED
Feb 22, 2023 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 22, 2022 EXRA
SOU EXTENSION 1 GRANTED
Dec 20, 2022 EX1G
SOU EXTENSION 1 FILED
Dec 20, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 20, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 3, 2022 NPUB
PUBLISHED FOR OPPOSITION
May 3, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 28, 2022 CNSA
ASSIGNED TO EXAMINER
Mar 28, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2021 NWOS
NEW APPLICATION ENTERED
Jul 12, 2021 NWAP